News Release
March 2, 2026
Organon Canada Marks International Women’s Day (IWD) with Company‑Wide Well‑Being Day
For the fifth year in a row, employees receive a paid day off to focus on their health or the health of women in their lives
Download Press ReleaseKirkland, Quebec – March 2, 2026 – Organon Canada, a global healthcare company with a mission to improve the health of women throughout their lives, proudly recognizes International Women’s Day as a moment to celebrate the social, economic, cultural, and political contributionsi of women and to shine a light on the importance of helping reduce the women’s health gap. In observance of this day, for the fifth consecutive year, Organon Canada employees will receive a paid day off on Friday, March 6. This dedicated day offers colleagues the opportunity to prioritize their well being or taking meaningful steps that support their health or the health of someone close to them.
In addition, inspired by the 2026 International Women’s Day ‘Give to Gain’ themeii, Organon Canada’s HER Employee Resource Group (ERG) launched an internal initiative that encourages generosity and collaboration. As part of this effort, employees may choose to contribute health and hygiene products to a women focused charity of their choice.
“International Women’s Day offers a meaningful moment to pause and reflect on the importance of women’s health, beginning with the well being of our own people. It reinforces our core belief that when women thrive, so do families, workplaces, and communities. This spirit of support and collective well being is central to the culture we continue to build at Organon Canada,” said Dominic Bégin, Interim Managing Director, Organon Canada, and co-sponsor of the HER ERG.
Rooted in Organon’s mission to help create a better and healthier every day for every woman, the company continues to help address health conditions that uniquely, disproportionately, or differently affect women. This emphasis is especially meaningful in Canada, where a recent McKinsey Health Institute report highlighted that women spend approximately 24% more time in poor health and disability than men and live with about 14 years of disability, compared with 11 years for men. iii Furthermore, the report indicates that closing the women’s health gap could generate at least $37 billion in annual economic benefits for Canada by 2040. iii
These insights underscore both the importance of advancing women’s health and the need for continued leadership and collaboration to help drive meaningful, measurable progress nationwide.
About Organon
Organon (NYSE: OGN) is a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. With a portfolio of over 70 products across Women’s Health, Biosimilars and General Medicines, Organon focuses on addressing health needs that uniquely, disproportionately or differently affect women, while expanding access to essential treatments in over 140 markets.
Headquartered in Jersey City, New Jersey, with a Canadian office in Kirkland, Quebec, Organon is committed to advancing access, affordability, and innovation in healthcare. Learn more at https://www.organon.ca and follow us on LinkedIn.
CA-NON-110963